After positive panel vote, Shionogi antibiotic scores US approval

Safety concerns linked with Shionogi’s antibiotic were put to bed by an expert panel to the FDA, who largely voted to back the drug for complicated urinary tract infections (cUTI) last month. On Friday, the US regulator followed suit, granting the treatment official approval.